Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4838853

CN(CCOc1ccc(-c2nc3cc(Br)cnc3[nH]2)cc1)CC(=O)N(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 4/20 0.41
CHEK2 O96017 1/20 0.39
ACHE P22303 6/20 0.39
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 2/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
P2RY12 Q9H244 1/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HDAC3 O15379 3/20 0.36
HDAC4 P56524 3/20 0.36
HDAC1 Q13547 3/20 0.36
HDAC7 Q8WUI4 3/20 0.36
HDAC2 Q92769 3/20 0.36
HDAC10 Q969S8 3/20 0.36
HDAC11 Q96DB2 3/20 0.36
HDAC8 Q9BY41 3/20 0.36
HDAC9 Q9UKV0 3/20 0.36
HDAC5 Q9UQL6 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4844122 0.90 HDAC6 (0.42) HDAC6CHEK2ACHEHDAC3HDAC4
Trifluoroacetic Acid SCHEMBL4834051 0.87 KDM4E (0.45) HDAC6ACHEALDH1A1KDM4EHDAC3
Trifluoroacetic Acid SCHEMBL4838222 0.87 ACHE (0.41) HDAC6CHEK2ACHENPC1HDAC3
Trifluoroacetic Acid SCHEMBL4834242 0.87 HDAC6 (0.40) HDAC6CHEK2ACHEPDE3BPDE3A
Trifluoroacetic Acid SCHEMBL4839525 0.85 HDAC6 (0.49) HDAC6CHEK2ACHEHDAC3HDAC4
Trifluoroacetic Acid SCHEMBL4843140 0.84 HDAC6 (0.50) HDAC6CHEK2ACHEHDAC3HDAC4
Trifluoroacetic Acid SCHEMBL4837229 0.81 KDM4E (0.40) HDAC6ALDH1A1KDM4EHDAC3HDAC4
SCHEMBL4845795 0.81 ACHE (0.46) HDAC6CHEK2ACHEHDAC3HDAC4
Trifluoroacetic Acid SCHEMBL4842876 0.81 CHEK2 (0.45) CHEK2NPC1ALDH1A1KDM4E
Trifluoroacetic Acid SCHEMBL4843197 0.80 TBK1 (0.51) CHEK2ACHEALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 HDAC6 981/4885CHEK2 309/4885ACHE 1390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.